Quarterly report pursuant to Section 13 or 15(d)

Revenue Information (Tables)

v3.20.1
Revenue Information (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of Revenue by Product Lines

Revenue by product lines was as follows:

 

    Three Months Ended  
    March 31,  
Product Line   2020     2019  
MicroParticle Catalyzed Biosensor (“MPC”)   $ -     $ 23,320  
Particle ImmunoFiltration Assay (“PIFA”)     354,458       576,317  
Other     9,057       12,486  
Total Revenue   $ 363,515     $ 612,123